Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for RVTY, sign up here.
Income Statement
Revenue
$2.8bn
Gross Profit
$1.5bn
Earning before Tax
$696.6m
Net Income
$693.1m
Net Income Common Shareholders
$693.1m
EPS
5.56
Balance Sheet
Cash
$913.2m
Debt
$4.0bn
Assets
$13.6bn
Liabilities
$5.7bn
Equity
$7.9bn
Enterprise Value
$16.4bn
Cash Flow Statement
Net Cash from Operations
$91.3m
Net Cash from Investing
$1.3bn
Net Cash from Financing
$-0.9bn
Net Cash Flow
$443.6m
Free Cash Flow
$9.9m
Free Cash Flow per Share
$0.08
Metrics
Price to Equity
19.46
Price to Equity (Damodaran)
19.66
Price to Book
1.71
Net Margin
0.25
Return on Equity
0.09
Return on Sales
0.30
Get immediate access to 5-years of reference grade data for RVTY for free.
Sign upRevvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Company Info
Industry
Diagnostics & Research
Employees
11,000
Address
940 Winter Street
Waltham, MA 02451
United States
Phone
781 663 6900
Website
Last Updated
2024-02-15
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.